Skip to main content
Signal8

Lynx1 Capital Management LP

Lynx1 Capital Management LP is an Investment Adviser institutional filer with the SEC under CIK 1910456, reporting 27 portfolio positions, with 26 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR/A
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-13

Top 10 portfolio positions

The largest reported holdings in Lynx1 Capital Management LP's most recent 13F filing, ranked by reported market value.

  1. GH RESEARCH PLC (GHRS)
  2. CULLINAN THERAPEUTICS INC (CGEM)
  3. STOKE THERAPEUTICS INC (STOK)
  4. AGIOS PHARMACEUTICALS INC (AGIO)
  5. C4 THERAPEUTICS INC (CCCC)
  6. KORRO BIO INC (KRRO)
  7. TSCAN THERAPEUTICS INC (TCRX)
  8. PRECISION BIOSCIENCES INC (DTIL)
  9. NEUPHORIA THERAPEUTICS INC (NEUP)
  10. PASSAGE BIO INC (PASG)
/